Search results
Regal Investment Advisors LLC Has $1.19 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 12 hours agoRegal Investment Advisors LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.6% in the 4th quarter, HoldingsChannel reports. The firm owned 10,800 shares ...
2 Magnificent Dividend Growth Stocks to Buy Now
Motley Fool via Yahoo Finance· 6 hours agoDividend growth stocks have long been revered by investors as powerful vehicles for compounding wealth over the long term. By consistently increasing...
Abbott secures FDA clearance for two over-the-counter glucose monitors
Reuters via Yahoo News· 1 day ago(Reuters) -Abbott Laboratories said on Monday the U.S. health regulator had cleared the company's...
FDA approves two new Abbott over-the-counter continuous glucose monitors
CNBC· 1 day agoAbbott Laboratories announced on Monday it received approval from the U.S. Food and Drug...
Abbott Laboratories's Options: A Look at What the Big Money is Thinking - Abbott Laboratories...
Benzinga· 1 day agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories ABT , and it's something market players shouldn't ignore. Our tracking of public options ...
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 1 day agoAbbott Laboratories gained U.S. clearance Monday for a pair of new continuous glucose monitors. But...
Abbott Laboratories (NYSE:ABT) Stake Raised by Westwood Holdings Group Inc.
ETF DAILY NEWS· 2 days agoWestwood Holdings Group Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The ...
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
Forbes· 2 days agoAbbott Laboratories Monday said the U.S. Food and Drug Administration has cleared for sale two new...
Abbott Laboratories loses bid to halt Glucerna class action
Reuters· 5 days agoLitigation claiming that Abbott Laboratories is marketing Glucerna shakes and nutritional powders with harmful ingredients can move forward, a California federal judge said Wednesday. , opens ...